Joint Bayesian models for validating spatial health-event databases against a gold standard: separating global and local discrepancies

📅 2026-05-22
📈 Citations: 0
Influential: 0
📄 PDF

career value

175K/year
🤖 AI Summary
This study addresses the lack of effective tools for spatial validation against a gold standard in existing candidate-reused spatial health event databases. The authors propose the first map-to-map, two-dimensional Bayesian hierarchical validation framework, which evaluates spatial agreement through both global (database-specific intercepts) and local (exceedance probabilities of error terms) dimensions, and systematically compares the performance of random effects models (REM), structured effects models (SEM), and shared component models (SCM). Experimental results demonstrate that the framework accurately detects global offsets under various perturbations, while REM and SEM exhibit high sensitivity and specificity in identifying local discrepancies. Application to Crohn’s disease data reveals that the candidate database exhibits an overall signal approximately 7% lower than the gold standard, yet maintains highly consistent spatial structure.
📝 Abstract
The reuse of medico-administrative and synthetic spatial data may overcome some limitations of population-based registries, provided rigorous validation is performed. However, no tool exists to spatially validate a candidate-for-reuse database (CFRD) against a gold standard (GS). We propose a Bayesian framework for two-dimensional (global and local) map-to-map validation of spatial health-event databases. We consider an error-model family (random [REM] and structured [SEM]) in which the CFRD is modelled as a departure from the GS. Both are compared with a shared component model (SCM). Global disagreement is assessed using the database-specific intercept difference ($RR_{\mathrm{global}}$), while local disagreement is measured by the exceedance probability of the database-specific error term. Disturbance scenarios included null, uniform, clustered, and random perturbations in the CFRD. Sensitivity, specificity, false detection rate, and Matthews Correlation Coefficient assessed detection performance. $RR_{\mathrm{global}}$ accurately recovered map-wide shifts across all models and scenarios. REM and SEM behaved were both sensitive and specific to local discrepancies. SCM was more conservative. Applied to Crohn's disease data from the EPIMAD registry and a CFRD, all models reached the same conclusion: the CFRD reproduced global and local spatial structures with an overall signal about 7\% lower. Extensions to other outcome distributions, spatio-temporal models and calibration constitute natural next steps. \textit{Keywords:} data reuse; spatial database validation; Bayesian hierarchical models; disease mapping; shared component model.
Problem

Research questions and friction points this paper is trying to address.

spatial database validation
data reuse
Bayesian hierarchical models
disease mapping
gold standard
Innovation

Methods, ideas, or system contributions that make the work stand out.

Bayesian hierarchical models
spatial database validation
global-local discrepancy
structured error model
shared component model
🔎 Similar Papers
M
Mathias Brugel
Univ Lille, CHU Lille, ULR 2694 - METRICS: Évaluation des technologies de santé et des pratiques médicales, F-59000 Lille, France; Department of Digestive Oncology, Hepatology and Gastroenterology, Centre Hospitalier de La Côte Basque, Bayonne, France
F
Florine Kempf
Univ Lille, CHU Lille, ULR 2694 - METRICS: Évaluation des technologies de santé et des pratiques médicales, F-59000 Lille, France
Camille Ternynck
Camille Ternynck
PhD applied mathematics - ingénieure de recherche
BiostatisticsSpatial statisticNonparametric statisticFunctional data analysisApplications
Marta Blangiardo
Marta Blangiardo
Professor of Biostatistics, MRC Centre for Environment and Health, Imperial College
Bayesian statisticshierarchical modelsBiostatisticsenvironmental epidemiology
M
Michaël Génin
Univ Lille, CHU Lille, ULR 2694 - METRICS: Évaluation des technologies de santé et des pratiques médicales, F-59000 Lille, France